The equilibrated blood sevoflurane concentrations show a rapid decrease after switching from ventilation for the human lung to cardiopulmonary bypass

• Published in: Nagoya journal of medical science Vol. 84; no. 1; pp. 163 - 168
• Main Authors: Tamura, Takahiro, Mori, Atsushi, Ishii, Akira, Nishiwaki, Kimitoshi
• Format: Journal Article
• Language: English
• Published: Japan Nagoya University 01.02.2022
• Subjects: Anesthetics, Inhalation; Cardiopulmonary Bypass - methods; Humans; Lung; Methyl Ethers - therapeutic use; Pilot Projects; Sevoflurane; Short Communicaton; cardiopulmonary bypass; human lung ventilation; sevoflurane; blood concentration; oxygenator
• ISSN: 0027-7622; 2186-3326
• DOI: 10.18999/nagjms.84.1.163

Volatile anesthetics (VAs) protect myocardial cells during cardiovascular surgeries, including cardiopulmonary bypass (CPB). In CPB, blood is gradually transferred from the body to a CPB unit until the target cardiac index is achieved, following which human lung (HL) ventilation is stopped. This pilot study aimed to evaluate changes in the blood sevoflurane concentrations 5 min after the start of CPB when its delivery to the oxygenator began after HL ventilation with sevoflurane was completed. Six patients were recruited and participated in this study. For each patient, the equilibrated blood sample, collected 20 min after starting the delivery of 1.7% sevoflurane (HL group), and another blood sample, collected 5 min after starting the CPB, were analyzed using gas chromatography equipped with a flame ionization detector. The mean (± standard deviation) sevoflurane concentrations in the HL and 5 min after starting CPB groups were 58.6 ± 4.7 and 14.5 ± 5.0 μg/ml, respectively ( < 0.01). In conclusion, the equilibrated blood sevoflurane concentrations showed a rapid decrease when switching from sevoflurane ventilation for the HL to CPB unless it was introduced to the oxygenator until completion of the switch.